National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 18567 [2023-06496]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 60 / Wednesday, March 29, 2023 / Notices
or early childhood development
services are provided to children. This
is consistent with the HHS mission to
protect and advance the physical and
mental health of the American people.
[FR Doc. 2023–06455 Filed 3–28–23; 8:45 am]
DEPARTMENT OF HOMELAND
SECURITY
BILLING CODE P
Coast Guard
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. USCG–2023–0242]
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR22–069 High
Impact, Interdisciplinary Science in NIDDK
Research Areas: Hematology (RC2).
Date: April 11, 2023.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Charlene J. Repique, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Blvd., Room 7013,
Bethesda, MD 20892, (301) 594–7791,
charlene.repique@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
19:20 Mar 28, 2023
[FR Doc. 2023–06496 Filed 3–28–23; 8:45 am]
BILLING CODE 4140–01–P
Roselyn Tso,
Director, Indian Health Service.
VerDate Sep<11>2014
Dated: March 24, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Jkt 259001
National Merchant Mariner Medical
Advisory Committee; April 2023
Meetings
U.S. Coast Guard, Department
of Homeland Security.
ACTION: Notice of federal advisory
committee meeting.
AGENCY:
The National Merchant
Mariner Medical Advisory Committee
(Committee) will conduct a series of
meetings over two days in Piney Point,
MD to discuss issues relating to medical
certification determinations for issuance
of licenses, certificates of registry,
merchant mariners’ documents, and
merchant mariner credentials; medical
standards and guidelines for the
physical qualifications of operators of
commercial vessels; medical examiner
education; and medical research.
DATES: Meetings: The National Merchant
Mariner Medical Advisory Committee is
scheduled to meet on Tuesday, April 25,
2023, from 9 a.m. until 4:30 p.m.
Eastern Daylight Time Zone (EDT) and
Wednesday, April 26, 2023, from 9 a.m.
until 4:30 p.m. (EDT). Committee
meetings on Tuesday, April 25 and
Wednesday, April 26, will include
periods during which the Committee
will break into subcommittees (open to
public). These meetings may adjourn
early if the Committee has completed its
business.
Comments and supporting
documentation: To ensure your
comments are received by Committee
members before the meeting, submit
your written comments no later than
April 18, 2023.
ADDRESSES: The meeting will be held at
the Paul Hall Media Center in Piney
Point, MD. Additional information
about the facility can be found at:
https://www.seafarers.org/training-andcareers/paul-hall-center/drivingdirections/.
Pre-registration Information: Preregistration is required for in-person
access to the meeting. If you are not a
member of the Committee and do not
represent the Coast Guard, you must
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
18567
request in-person attendance by
contacting the individual listed in the
FOR FURTHER INFORMATION CONTACT
section of this notice to be allowed entry
to the meeting.
The National Merchant Mariner
Medical Advisory Committee is
committed to ensuring all participants
have equal access regardless of
disability status. If you require
reasonable accommodation due to a
disability to fully participate, please
email Ms. Pamela Moore at
pamela.j.moore@uscg.mil or call at (202)
372–1361 as soon as possible.
Instructions: You are free to submit
comments at any time, including orally
at the meetings as time permits, but if
you want Committee members to review
your comment before the meeting,
please submit your comments no later
than April 18, 2023. We are particularly
interested in comments regarding the
topics in the ‘‘Agenda’’ section below.
We encourage you to submit comments
through the Federal eRulemaking Portal
at https://www.regulations.gov. If your
material cannot be submitted using
https://www.regulations.gov, call or
email the individual in the FOR FURTHER
INFORMATION CONTACT section of this
document for alternate instructions. You
must include the docket number USCG–
2023–0242. Comments received will be
posted without alteration at https://
www.regulations.gov, including any
personal information provided. You
may wish to review the Privacy and
Security notice available on the
homepage https://www.regulations.gov,
and DHS’s eRulemaking System of
Records notice (85 FR 14226, March 11,
2020). If you encounter technical
difficulties with comment submission,
contact the individual listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice.
Docket Search: Documents mentioned
in this notice as being available in the
docket, and all public comments, will
be in our online docket at https://
www.regulations.gov and can be viewed
by following that website’s instructions.
Additionally, if you go to the online
docket and sign-up for email alerts, you
will be notified when comments are
posted.
FOR FURTHER INFORMATION CONTACT: Ms.
Pamela Moore, Alternate Designated
Federal Officer of the National Merchant
Mariner Medical Advisory Committee,
telephone (202) 372–1361, or email
pamela.j.moore@uscg.mil.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is in compliance with
the Federal Advisory Committee Act
(Pub. L. 117–286, 5 U.S.C., ch. 10). The
Committee is authorized by section 601
E:\FR\FM\29MRN1.SGM
29MRN1
]]>Agencies
[Federal Register Volume 88, Number 60 (Wednesday, March 29, 2023)]
[Notices]
[Page 18567]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06496]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; PAR22-069 High Impact,
Interdisciplinary Science in NIDDK Research Areas: Hematology (RC2).
Date: April 11, 2023.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
Diabetes and Digestive and Kidney Diseases, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Charlene J. Repique, Ph.D., Scientific Review
Officer, NIDDK/Scientific Review Branch, National Institutes of
Health, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, (301)
594-7791, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: March 24, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-06496 Filed 3-28-23; 8:45 am]
BILLING CODE 4140-01-P
